about
Aberrant quantity and localization of Aurora-B/AIM-1 and survivin during megakaryocyte polyploidization and the consequences of Aurora-B/AIM-1-deregulated expressionZcchc11-dependent uridylation of microRNA directs cytokine expressionVascular smooth muscle polyploidization as a biomarker for aging and its impact on differential gene expressionThe A2B adenosine receptor protects against inflammation and excessive vascular adhesion.The RNA uridyltransferase Zcchc6 is expressed in macrophages and impacts innate immune responses.Roads to polyploidy: the megakaryocyte example.Terminal uridyltransferase enzyme Zcchc11 promotes cell proliferation independent of its uridyltransferase activityAnimal models for the study of adenosine receptor function.Hepatocyte-specific mutation of both NF-κB RelA and STAT3 abrogates the acute phase response in miceLeukemia inhibitory factor signaling is required for lung protection during pneumoniaType I alveolar epithelial cells mount innate immune responses during pneumococcal pneumonia.Zcchc11 uridylates mature miRNAs to enhance neonatal IGF-1 expression, growth, and survival.Alveolar epithelial STAT3, IL-6 family cytokines, and host defense during Escherichia coli pneumoniaRoles of STAT3 in protein secretion pathways during the acute-phase response.Vascular smooth muscle cell polyploidy: an adaptive or maladaptive response?Functions and regulation of NF-kappaB RelA during pneumococcal pneumoniaRoles of interleukin-6 in activation of STAT proteins and recruitment of neutrophils during Escherichia coli pneumonia.Mechanisms of the hepatic acute-phase response during bacterial pneumonia.Conditional overexpression of transgenes in megakaryocytes and platelets in vivo.Increased polyploidy in aortic vascular smooth muscle cells during aging is marked by cellular senescence.A(3) adenosine receptor deficiency does not influence atherogenesis.Vascular smooth muscle cell polyploidization involves changes in chromosome passenger proteins and an endomitotic cell cycleOncostatin M causes eotaxin-1 release from airway smooth muscle: Synergy with IL-4 and IL-13
P50
Q28509282-960D0A71-893D-4365-8F8D-3615480B8ADAQ28511274-0C69992B-496E-47A6-A008-BFBA3D9960C0Q28568654-10F1BEF4-CAF1-457C-8918-56CCC5E0FB19Q30477474-07F6D34B-1D2E-4B02-A655-35F6BE7CB072Q33859901-11B64172-DADA-47C2-A5D6-C81AE569FDF9Q34504475-DCA02A19-B2E0-42EE-83DD-D36804C982E4Q35605080-5F754226-917B-495C-8E02-414DB48B7EF9Q35897185-2FBCC567-3705-4328-B9D5-2210E07AF99DQ35913668-0ACAEF5C-7E43-4508-BA0F-0CC852BCA288Q36016336-C3B20C34-9BE2-41C7-995E-079B7F66B0FBQ36179571-0D0B75F4-D7F1-47CD-BEC0-59AEBB29DEA9Q36433836-ACE9C4C4-D632-403D-93E8-8A0EA764307DQ36676000-A1A61E0D-7335-4740-A10C-B217399D89DBQ36826883-78A5E57B-14C0-406F-9AF5-3BA879A38454Q37052836-98581226-4CB8-4AE9-821C-6F41F7D6731EQ37172096-1745F670-F440-4D97-A91F-2602899641FAQ37172129-C7A932A4-B722-4A01-B6E4-FB29C1AD966AQ37204446-D6F14678-30B1-4A93-89B2-D25A4FC97578Q42194316-15E71120-B5DF-49EE-BC37-CA3F604004E6Q42272254-FA608573-65B1-4773-B92E-CA1E30FE5749Q44982781-FAB1A8D2-44BA-4228-8D7A-589768C1BF60Q58486838-841526E9-F876-41E6-B3E7-BE37A113EFCFQ60609577-BACF9E22-EA6C-4F63-AE67-744197BCAA1D
P50
description
researcher ORCID ID = 0000-0003-4647-2962
@en
wetenschapper
@nl
name
Matthew R Jones
@ast
Matthew R Jones
@en
Matthew R Jones
@nl
ماثيو آر جونز
@ar
type
label
Matthew R Jones
@ast
Matthew R Jones
@en
Matthew R Jones
@nl
ماثيو آر جونز
@ar
prefLabel
Matthew R Jones
@ast
Matthew R Jones
@en
Matthew R Jones
@nl
ماثيو آر جونز
@ar
P106
P21
P31
P496
0000-0003-4647-2962